Thomas C. Varvaro

Thomas C. Varvaro discloses dealings in Mabvax Therapeutics Holdings, Inc. to SEC (Form 4). Over a trading history stretching from 4 April 2016 to 3 April 2018, the count stands at 6 filings.

On the market, this insider has only sold: 2 sales, €25k in total. The rest of the record consists of 4 option exercises. So far in 2018, the count stands at no purchases and 2 sales.

The latest filing, published on 3 April 2018, reports an option exercise in Mabvax Therapeutics Holdings, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.